Comparison of FOLFOX and DOF regimens as first-line treatment in East Asian patients with advanced gastric cancer

BACKGROUND: Our study retrospectively assesses the safety and efficacy of the FOLFOX (oxaliplatin, fluorouracil, and leucovorin) versus DOF (docetaxel, oxaliplatin, and fluorouracil) regimens in untreated locally advanced gastric cancer (AGC). PATIENTS AND METHODS: A total of 108 patients underwent...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Onco Targets Ther
Hlavní autoři: Liu, Mengyao, Hu, Guofang, Wang, Yuan, Guo, Jun, Liu, Liyan, Han, Xiao, Wang, Zhehai
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2018
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5775733/
https://ncbi.nlm.nih.gov/pubmed/29398919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S149624
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky